Contact
Please use this form to send email to PR contact of this press release:
Imara Receives Orphan Drug Designation from the European Commission for IMR-687 for the Treatment of Sickle Cell Disease
TO:
Please use this form to send email to PR contact of this press release:
Imara Receives Orphan Drug Designation from the European Commission for IMR-687 for the Treatment of Sickle Cell Disease
TO: